mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.01 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.02 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.02 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.02 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.02 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.02 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.02 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.02 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.02 |
mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.02 |